Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107590923 | 10759092 | 3 | F | 201501 | 20160830 | 20150203 | 20160902 | PER | US-PFIZER INC-2015045349 | PFIZER | 45.00 | YR | F | Y | 77.00000 | KG | 20160902 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107590923 | 10759092 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | L01035 | 21446 | 75 | MG | CAPSULE, HARD | BID | |||||
| 107590923 | 10759092 | 2 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 107590923 | 10759092 | 3 | SS | LYRICA | PREGABALIN | 1 | 21446 | CAPSULE, HARD | |||||||||||
| 107590923 | 10759092 | 4 | C | DICLOFENAC | DICLOFENAC | 1 | Oral | 75 MG, 2X/DAY | 0 | 75 | MG | TABLET | BID | ||||||
| 107590923 | 10759092 | 5 | C | DICLOFENAC | DICLOFENAC | 1 | 0 | TABLET | |||||||||||
| 107590923 | 10759092 | 6 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | CAPSULE | QD | ||||||
| 107590923 | 10759092 | 7 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | 15 MG, 1X/DAY | 0 | 15 | MG | TABLET | QD | |||||||
| 107590923 | 10759092 | 8 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 50 MG, 1X/DAY 2-50MG TABS AT BEDTIME | 0 | 100 | MG | TABLET | QD | |||||||
| 107590923 | 10759092 | 9 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 10 MG, 2X/DAY | 0 | 10 | MG | TABLET | BID | ||||||
| 107590923 | 10759092 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 850 MG, 2X/DAY | 0 | 850 | MG | TABLET | BID | ||||||
| 107590923 | 10759092 | 11 | C | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 1 G, 2X/DAY | 0 | 1 | G | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107590923 | 10759092 | 1 | Hypoaesthesia |
| 107590923 | 10759092 | 2 | Pain in extremity |
| 107590923 | 10759092 | 3 | Diabetic neuropathy |
| 107590923 | 10759092 | 4 | Hypoaesthesia |
| 107590923 | 10759092 | 5 | Pain in extremity |
| 107590923 | 10759092 | 6 | Depression |
| 107590923 | 10759092 | 7 | Bipolar disorder |
| 107590923 | 10759092 | 8 | Insomnia |
| 107590923 | 10759092 | 9 | Type 2 diabetes mellitus |
| 107590923 | 10759092 | 10 | Diabetes mellitus |
| 107590923 | 10759092 | 11 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107590923 | 10759092 | Condition aggravated | |
| 107590923 | 10759092 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |